NM_006495.4:c.157G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006495.4(EVI2B):​c.157G>A​(p.Gly53Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00144 in 1,614,116 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0076 ( 18 hom., cov: 32)
Exomes 𝑓: 0.00080 ( 22 hom. )

Consequence

EVI2B
NM_006495.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.283

Publications

5 publications found
Variant links:
Genes affected
EVI2B (HGNC:3500): (ecotropic viral integration site 2B) Involved in positive regulation of granulocyte differentiation. Predicted to be integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029623508).
BP6
Variant 17-31305453-C-T is Benign according to our data. Variant chr17-31305453-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376784.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00763 (1161/152226) while in subpopulation AFR AF = 0.0269 (1117/41536). AF 95% confidence interval is 0.0256. There are 18 homozygotes in GnomAd4. There are 538 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006495.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVI2B
NM_006495.4
MANE Select
c.157G>Ap.Gly53Arg
missense
Exon 2 of 2NP_006486.3
NF1
NM_001042492.3
MANE Select
c.4836-20367C>T
intron
N/ANP_001035957.1P21359-1
NF1
NM_000267.4
c.4773-20367C>T
intron
N/ANP_000258.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVI2B
ENST00000330927.5
TSL:1 MANE Select
c.157G>Ap.Gly53Arg
missense
Exon 2 of 2ENSP00000333779.4P34910-1
ENSG00000265118
ENST00000578584.5
TSL:2
c.*206G>A
3_prime_UTR
Exon 3 of 3ENSP00000463981.2J3QR06
NF1
ENST00000358273.9
TSL:1 MANE Select
c.4836-20367C>T
intron
N/AENSP00000351015.4P21359-1

Frequencies

GnomAD3 genomes
AF:
0.00761
AC:
1157
AN:
152108
Hom.:
18
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0269
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00210
AC:
527
AN:
251438
AF XY:
0.00139
show subpopulations
Gnomad AFR exome
AF:
0.0290
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000796
AC:
1164
AN:
1461890
Hom.:
22
Cov.:
32
AF XY:
0.000641
AC XY:
466
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0290
AC:
971
AN:
33480
American (AMR)
AF:
0.00134
AC:
60
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000162
AC:
18
AN:
1112008
Other (OTH)
AF:
0.00171
AC:
103
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
75
150
225
300
375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00763
AC:
1161
AN:
152226
Hom.:
18
Cov.:
32
AF XY:
0.00723
AC XY:
538
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0269
AC:
1117
AN:
41536
American (AMR)
AF:
0.00183
AC:
28
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68000
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00316
Hom.:
16
Bravo
AF:
0.00899
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0261
AC:
115
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00238
AC:
289
Asia WGS
AF:
0.00318
AC:
11
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
3.6
DANN
Benign
0.57
DEOGEN2
Benign
0.073
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.53
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.97
L
PhyloP100
0.28
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.033
Sift
Benign
0.28
T
Sift4G
Benign
0.54
T
Polyphen
0.0040
B
Vest4
0.077
MVP
0.36
MPC
0.041
ClinPred
0.0013
T
GERP RS
0.80
Varity_R
0.10
gMVP
0.22
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9903564; hg19: chr17-29632471; API